Extended phase II study of paclitaxel as a 3-h infusion in patients with ovarian cancer previously treated with platinum

Author： du Bois A.   Luck H.J.   Buser K.   Meerpohl H.G.   Sessa C.   Klaassen U.   Meden H.   Bochtler H.   Diergarten K.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.33, Iss.3, 1997-03, pp. : 379-384

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Phase II and Pharmacokinetic Study of Weekly 72-h Topotecan Infusion in Patients with Platinum-Resistant and Paclitaxel-Resistant Ovarian Carcinoma

By Rose P.G.   Gordon N.H.   Fusco N.   Fluellen L.   Rodriguez M.   Ingalls S.T.   Hoppel C.L.  

Gynecologic Oncology, Vol. 78, Iss. 2, 2000-08 ,pp. : 228-234

Elsevier

Access to resources Recommend Favorite

Phase 2 Trial of Single Agent Ifosfamide/Mesna in Patients with Platinum/Paclitaxel Refractory Ovarian Cancer Who Have Not Previously Been Treated with an Alkylating Agent

By Markman M.   Kennedy A.   Sutton G.   Hurteau J.   Webster K.   Peterson G.   Kulp B.   Belinson J.  

Gynecologic Oncology, Vol. 70, Iss. 2, 1998-08 ,pp. : 272-274

Elsevier

Access to resources Recommend Favorite

Phase I Study with a Weekly 1 h Infusion of Paclitaxel in Heavily Pretreated Patients with Metastatic Breast and Ovarian Cancer

By Klaassen U.   Wilke H.   Strumberg D.   Eberhardt W.   Korn M.   Seeber S.  

European Journal of Cancer, Vol. 32, Iss. 3, 1996-03 ,pp. : 547-549

Elsevier

Access to resources Recommend Favorite

A Phase I Study of Weekly Topotecan and Paclitaxel in Previously Treated Epithelial Ovarian Carcinoma Patients

By Homesley H.   Benigno B.   Williams J.   Vaccarello L.  

Gynecologic Oncology, Vol. 87, Iss. 2, 2002-11 ,pp. : 171-177

Academic Press

Access to resources Recommend Favorite

Phase II Evaluation of 24-h Continuous Infusion Topotecan in Recurrent, Potentially Platinum-Sensitive Ovarian Cancer: A Gynecologic Oncology Group Study

By Markman M.   Blessing J.A.   Alvarez R.D.   Hanjani P.   Waggoner S.   Hall K.  

Gynecologic Oncology, Vol. 77, Iss. 1, 2000-04 ,pp. : 112-115

Elsevier

Access to resources Recommend Favorite